Evidence map›Paper›PMID 29708527›Full record

ArticleJournal of visualized experiments : JoVE2018

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.

Francesca Ruscitti, Francesca Ravanetti, Gaetano Donofrio, Yanto Ridwan, Paula van Heijningen, Jeroen Essers, Gino Villetti, Antonio Cacchioli, Wim Vos, Franco Fabio Stellari

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. [European journal of nuclear medicine and molecular imaging · 2021
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Francesca RuscittiCorporate Preclinical R&D, Chiesi Farmaceutici S.p.A.
Francesca RavanettiDepartment of Veterinary Science, University of Parma.
Gaetano DonofrioDepartment of Veterinary Science, University of Parma.
Yanto RidwanDepartment of Molecular Genetics, Erasmus MC.
Paula van HeijningenDepartment of Molecular Genetics, Erasmus MC.
Jeroen EssersDepartment of Molecular Genetics, Vascular Surgery, Radiation Oncology, Erasmus MC.
Gino VillettiCorporate Preclinical R&D, Chiesi Farmaceutici S.p.A.
Antonio CacchioliDepartment of Veterinary Science, University of Parma.
Wim VosFluidda NV.
Franco Fabio StellariCorporate Preclinical R&D, Chiesi Farmaceutici S.p.A.; FB.Stellari@chiesi.com.
Erasmus MC · NLUniversity of Parma · ITFluidda (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by the progressive and irreversible destruction of lung architecture, which causes significant deterioration in lung function and subsequent death from respiratory failure. The pathogenesis of IPF in experimental animal models has been induced by bleomycin administration. In this study, we investigate an IPF-like mouse model induced by a double intratracheal bleomycin instillation. Standard histological assessments used for studying lung fibrosis are invasive terminal procedures. The goal of this work is to monitor lung fibrosis through noninvasive imaging techniques such as Fluorescent Molecular Tomography (FMT) and Micro-CT. These two technologies validated with histology findings could represent a revolutionary functional approach for real time non-invasive monitoring of IPF disease severity and progression. The fusion of different approaches represents a step further for understanding the IPF disease, where the molecular events occurring in a pathological condition can be observed with FMT and the subsequent anatomical changes can be monitored by Micro-CT.

Indexed as

AnimalsBleomycinCell Culture TechniquesDisease Models, AnimalDisease ProgressionFluorescenceLongitudinal StudiesLungMiceMultimodal ImagingPulmonary FibrosisTomography, X-Ray ComputedX-Ray MicrotomographyBleomycin

Identifiers

PMID29708527
PMCPMC5933503
OpenAlexW2799803082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.